Evion Group (ASX:EVG) has a better story than it did a month ago. It also has one detail investors should not skip.
The ASX graphite and critical minerals developer has told the market that Panthera Graphite Technologies, its 50:50 expandable graphite joint venture with Metachem Manufacturing Co. in India, delivered US$530,000 of EBITDA for the year ended 31 March 2026. The company later clarified that the result was unaudited at the date of the original announcement, because the formal audit report had not yet been signed, although Evion said it did not expect the reported result to change.
That combination is the story. The commercial signal is real enough to watch. The accounting footnote is real enough to respect.
The India JV has started doing more than telling a story
For years, Evion’s pitch has been built around future graphite demand, downstream processing and the Maniry project in Madagascar. The Panthera update changes the tone because it gives investors a live operating data point.
The joint venture reported US$1.722 million of revenue, gross profit of US$939,000 and EBITDA of US$530,000 for FY2026, with a gross profit margin of 54.5%. Evion said the operation achieved profitability at 20% to 25% of nameplate capacity, with expandable graphite realisations of US$3,100 to US$3,400 per metric tonne.
That is not a company-making number by itself. It is too early and too small for that. But it does give the market something more useful than a slide deck assumption: a working plant, a product price and an early margin profile.
The audit clarification is not a footnote to ignore
The sharper read is not simply “US$530,000 EBITDA”. It is “US$530,000 EBITDA, still awaiting formal audit sign-off at the time of clarification”.
Evion’s 12 June clarification said the audit was “largely concluded” and that the company did not expect any change to the year-end results. It also amended the announcement to remove references to audited financial results.
That matters because small-cap resource stories often trade on confidence before they trade on scale. A signed audit report would tidy the file. Until then, the result is encouraging, but not fully closed.
The company says it does not expect the numbers to change. Investors now have a simple test: whether the final audit report lands cleanly and on time.
The scale-up numbers are where the debate begins
Evion’s own projections point to a much larger version of Panthera. The company says ramping to 2,500 metric tonnes per annum would support projected EBITDA of US$3.4 million, while a Stage 2 expansion to 4,000 metric tonnes per annum targets EBITDA of US$5.8 million.
This is where the attraction and the risk sit side by side.
The positive read is that Panthera appears to have proven demand and pricing at modest volumes. If those unit economics hold as output rises, Evion could become less dependent on long-dated project milestones and more connected to operating cash flow.
The cautious read is that scaling a processing operation is not the same as modelling one. More volume can bring working-capital strain, customer concentration risk, price pressure and execution issues. The early margin is useful, but the next 1,000 tonnes will matter more than the first 720 tonnes.
The A$7.24 million raise changes the runway and the share count
Evion has also strengthened its funding position. On 29 May 2026, the company said its placement had been upsized to approximately A$7.24 million before costs, through the issue of 241,333,333 shares at A$0.03 per share. Tranche 1 raised about A$4.3 million, while Tranche 2 remains subject to shareholder approval at an expected early July 2026 meeting.
The placement helps fund the next phase. It also dilutes existing holders.
That is the trade-off with Evion right now. The company is trying to move from a project story into an operating and development platform, spanning graphite in India and Madagascar, plus a new US fluorspar option in Nevada. That broader platform gives the market more to value, but it also gives management more to execute.
The next clean update matters more than the headline number
The next useful update is not another large target. It is confirmation.
Investors will be watching for the formal Panthera audit sign-off, evidence that sales volumes are moving toward the 2,500 metric tonne target, and progress on the shareholder vote for Tranche 2 of the placement. The Maniry permitting path in Madagascar and early field work at Carp in Nevada will also matter, but Panthera is the immediate proof point.
Evion has given the market a more interesting story. The next step is to make it cleaner, larger and harder to dismiss.
